DHG Pharmaceutical JSC Balance Sheet

Financials in millions VND. Fiscal year is January - December.

Millions VND. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	129,896	62,858	94,134	34,018	43,374
Short-Term Investments	2,024,000	2,745,000	1,960,000	2,265,000	1,975,000
Cash & Short-Term Investments	2,153,896	2,807,858	2,054,134	2,299,018	2,018,374
Cash Growth	-23.29%	36.69%	-10.65%	13.90%	-1.40%
Accounts Receivable	584,930	523,860	528,859	279,862	315,113
Other Receivables	79,726	86,838	96,075	81,417	77,757
Receivables	664,792	610,955	625,192	361,537	393,141
Inventory	1,024,619	1,115,429	1,534,636	1,250,834	1,072,606
Prepaid Expenses	9,996	8,653	8,007	10,201	5,827
Other Current Assets	35,466	61,109	420,224	297,183	237,346
Total Current Assets	3,888,768	4,604,004	4,642,193	4,218,772	3,727,293
Property, Plant & Equipment	1,012,567	1,066,375	1,187,884	678,171	631,658
Long-Term Investments	4,630	4,438	4,175	3,860	4,578
Other Intangible Assets	174,420	178,106	181,861	201,812	205,780
Long-Term Deferred Tax Assets	25,929	18,340	16,872	15,845	17,535
Other Long-Term Assets	67,567	87,982	77,489	49,726	30,822
Total Assets	5,173,882	5,959,243	6,110,474	5,168,187	4,617,666
Accounts Payable	391,631	167,297	217,976	364,379	201,220
Accrued Expenses	432,467	339,445	313,579	227,615	257,956
Short-Term Debt	-	649,914	572,165	114,723	207,391
Current Income Taxes Payable	5,272	22,417	17,365	12,678	4,208
Current Unearned Revenue	42,842	48,507	43,702	34,043	49,609
Other Current Liabilities	93,737	562,713	24,454	58,098	37,332
Total Current Liabilities	965,950	1,790,293	1,189,242	811,537	757,716
Other Long-Term Liabilities	70,667	74,195	68,298	65,113	66,807
Total Liabilities	1,036,616	1,864,488	1,257,540	876,650	824,523
Common Stock	1,307,461	1,307,461	1,307,461	1,307,461	1,307,461
Additional Paid-In Capital	6,779	6,779	6,779	6,779	6,779
Retained Earnings	2,823,026	2,780,515	3,538,695	2,977,297	2,475,770
Total Common Equity	4,137,265	4,094,755	4,852,935	4,291,537	3,790,010
Minority Interest	-	-	-	-	3,134
Shareholders' Equity	4,137,265	4,094,755	4,852,935	4,291,537	3,793,144
Total Liabilities & Equity	5,173,882	5,959,243	6,110,474	5,168,187	4,617,666
Total Debt	-	649,914	572,165	114,723	207,391
Net Cash (Debt)	2,153,896	2,157,944	1,481,969	2,184,294	1,810,982
Net Cash Growth	-0.19%	45.61%	-32.15%	20.61%	-1.30%
Net Cash Per Share	16473.88	16504.84	11334.72	16706.39	13851.14
Filing Date Shares Outstanding	130.75	130.75	130.75	130.75	130.75
Total Common Shares Outstanding	130.75	130.75	130.75	130.75	130.75
Working Capital	2,922,819	2,813,711	3,452,951	3,407,236	2,969,577
Book Value Per Share	31643.51	31318.38	37117.25	32823.45	28987.56
Tangible Book Value	3,962,845	3,916,649	4,671,074	4,089,725	3,584,230
Tangible Book Value Per Share	30309.48	29956.15	35726.31	31279.91	27413.67
Buildings	776,236	776,502	575,489	578,613	528,464
Machinery	1,423,734	1,374,826	1,029,566	903,189	866,975
Construction In Progress	44,158	48,614	553,594	92,596	69,508

Source: S&P Global Market Intelligence. Standard template. Financial Sources.